History

Noyoung Park appointed as Representative Director

Received Labor-Management Peace Award

Released first generic 'Nagran ODT'

YP-P10, a new drug for the treatment of dry eye, received FDA approval for its Phase 2 clinical trial

Designated by the city of Jecheon, Chungbuk as a “female-friendly workplace

Received an “A” grade evaluation from Korea’s Fair Trade Commission

Yuyu celebrated the 80th anniversary of its establishment

Established collaborative research partnership with UCLA University (USA) for the treatment of multiple sclerosis

Yuyu received certification for its Global Anti-Corruption Management System

Accumulated sales of First Generic Newmacor exceed 40 million capsules

Establishment of new and renewable energy facilities in Jecheon Factory

Introduced to CNN as a social contribution company related to COVID-19

Appointment of CEO Wonsang Yu as president

Establishment of Yuyu Medicals

Appointment of CEO Wonsang Yu

The 100th anniversary of the founder Teckhan Yu's birthday

Selected as Innovative Pharmaceutical Company in Asia Pacific

Seoul office building remodeling completed

Signed MOU with Korean Society of Osteoporosis and Korea Women's Health and Osteoporosis Foundation

Selected as an excellent company for youth jobs in Chungcheongbuk-do

Expansion of the Central Research Center

Released first generic 'Newmacor'

Certified as an excellent family-friendly company by the Ministry of Gender Equality and Family

Awarded a prestigious longevity company by the Ministry of Trade, Industry and Energy

Selected as an excellent employment company on the 7th Chungbuk Entrepreneur's Day (Governor's Commendation)

Signed export MOU with Huanghua Group in China

Signed LOI with Bio-Pharmaceuticals, Sdn. Bhd. in Malaysia

Exported osteoporosis treatment drug 'Maxmarvil' to Thailand

Marketing using big data for 'Venoplus Gel' is the first of its kind in the Korea pharmaceutical industry

70th anniversary event, Yuyu celebrated the 70th anniversary of its establishment

Released antidepressant over-the-counter drug 'Noiromin'

Release of vitamin C 'YUPANC pop'

Opened Chuncheon Research Center

Release of chronic respiratory infection treatment product 'Umcamin syrup'

'Yuclid' won the Technology Award at the New Drug Development Research Association New Drug Development Awards

Changed company name to Yuyu Pharma

Release of an improved antiplatelet drug 'Yuclid'

Establishment of International Scientific Standard (ISS)

Chairman Seungpil Yu received the Presidential Citation on Taxpayers' Day

Release of intestinal medicine 'Syubaton'

Contract with Swiss Zeller to introduce 'ZE440', a treatment for perimenstrual syndrome

Relocated to the newly-constructed Jecheon Factory

Establishment of Yuyu Healthcare

Establishment of Yuyu Teijin Medicare joint venture

Released an improved new drug for osteoporosis treatment 'Maxmarvil'

Chairman Seungpil Yu received the National Order of Merit, Moran Medal

Seungpil Yu appointed as Chairman of the Korea Pharmaceutical Association

Release of nasal cleanser 'PHYSIOMER'

Technical alliance with Gardo of Argentina (release of osteoporosis treatment 'Mavil tablet')

Obtained manufacturing license for Ginkgo biloba extract for the first time in Korea

Acquired a patent for the manufacturing method of Ginkgo biloba extract

Released 'Solong Capsule', a gastric ulcer treatment with Japan's Taisho

'Tanamin tablet' Germany Dr. Willmar Schwabe with 'EGb761' supply contract, released in Korea

Completion of Seoul office building in Sindang-dong

The release of the biopharmaceutical 'Salbiwon' under an exclusive supply contract with Japan's Kokando

Establishment of the Central Research Center (the 17th accreditation by the Ministry of Science and Technology)

Establishment of Yuyu Calmic, a joint venture with Rentokil of the United Kingdom

Seungpil Yu appointed as President of Yuyu Pharma

Technical alliance with Sanofi group of France (release of blood circulation improving agent 'Clid')

Technical alliance with Schwabe of West Germany (release of brain and peripheral circulation improving agent 'Tanamin')

Establishment of Yuyu Fumakilla, a joint venture between Korea and Japan

Technical alliance with Taisho of Japan (release of muscle relaxant 'Rinlaxer')

Changgi Jeon appointed as President of Yuyu Pharma

Adoption of the Chairman-President system. Teckhan Yu appointed as Chairman and Gwangsu Go appointed as President

Technical alliance with Dainippon of Japan (release of anemia treatment 'Burutal Injection')

Technical alliance with Siegteied of Switzerland (release of pain reliever 'Spasla')

Disclosure of enterprises, listing stocks, and establishment of trade unions

Technical partnership with West Germany Dr. Willmar Schwabe (release of a treatment for swelling 'Venoplant')

Technical alliance with Maiji seika of Japan (release of antibiotic 'Maymycin')

Established Yuyu Cultural Foundation

Establishment of Korea Upjohn, a joint venture between Korea and the USA

Technical alliance with Upjohn of the USA (introduced antibiotic new drug 'Lincocin')

Release of 'YUPANC A'

Developed 'Yuyumethionine (DL methionine)' and released 'VENAPOLLO A Soft Capsule'

Development of 'VENAPOLLO', the first soft capsule nutritional supplement in Korea

Released vitamin C formulation 'YUPANC'

Completion of Anyang factory

Changed company name to Yuyu Industrial Co., Ltd.

Produced 'VitaM Tablet', a multivitamin drug for the first time in Korea

Produced 'Furantival tablet', a psychoactive drug

Production of the tuberculosis drug "Eupaszit"

Changed company name to Yuhan Industrial Co., Ltd., purchased its headquarters in Chungmu-ro, Jung-gu, Seoul, and started manufacturing medicine.

Yuyu’s founder, Chairman Teckhan Yu, elected as the fourth Chairman of the Korean Pharmaceutical Industry Association

Founder Teckhan Yu establishes Yuyu Trading Co., Ltd. (Yuyu Pharma)